Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | PYGB | P11216 | 1/20 | 0.33 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.33 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.33 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.33 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.33 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.32 |
| ▸ | TYR | P14679 | 4/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23640150 | 0.83 | L3MBTL1 (0.42) | L3MBTL1MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL19966790 | 0.83 | L3MBTL1 (0.42) | L3MBTL1MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL19790925 | 0.82 | L3MBTL1 (0.36) | L3MBTL1MAPTSYNJ2ALDH1A1TYR | |
| SCHEMBL10176794 | 0.80 | LGALS1 (0.47) | L3MBTL1MAPTALDH1A1PYGBLGALS3 | |
| SCHEMBL14278435 | 0.80 | LGALS1 (0.47) | L3MBTL1MAPTALDH1A1PYGBLGALS3 | |
| SCHEMBL14191382 | 0.80 | LGALS1 (0.47) | L3MBTL1MAPTALDH1A1PYGBLGALS3 | |
| SCHEMBL12221718 | 0.80 | LGALS1 (0.47) | L3MBTL1MAPTALDH1A1PYGBLGALS3 | |
| SCHEMBL23640046 | 0.80 | LGALS1 (0.47) | L3MBTL1MAPTALDH1A1PYGBLGALS3 | |
| SCHEMBL21339944 | 0.80 | LGALS1 (0.47) | L3MBTL1MAPTALDH1A1PYGBLGALS3 | |
| SCHEMBL9914077 | 0.80 | LGALS1 (0.47) | L3MBTL1MAPTALDH1A1PYGBLGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210214607-A1 | LONG WAVELENGTH EMITTING CHEMILUMINESCENT PROBES | NEMIS TECHNOLOGIES AG (CH) | 2021-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210214607-A1 | LONG WAVELENGTH EMITTING CHEMILUMINESCENT PROBES | VEGFA, GUSB, NR2E3 | L3MBTL1 562/4885MAPT 3254/4885SYNJ2 4565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.